Prazosin Hydrochloride recall : A significant recall has been issued for more than 580,000 bottles of a commonly prescribed blood pressure medication due to concerns over elevated levels of a potentially cancer-causing chemical impurity. The Food and Drug Administration (FDA) has alerted the public and healthcare providers about this important safety issue, urging patients to consult their doctors before making any changes to their medication regimen.
What Is Being Recalled?
The medication involved in the recall is Prazosin Hydrochloride, which is widely used to treat high blood pressure and, in some cases, prescribed off-label for post-traumatic stress disorder (PTSD) symptoms such as nightmares and sleep issues. The recall affects three dosages of the drug: 1 mg, 2 mg, and 5 mg capsules, distributed by Teva Pharmaceuticals.
The FDA identified the presence of “N-nitroso Prazosin impurity C,” a nitrosamine compound known to be potentially carcinogenic, in levels exceeding the agency’s acceptable safety limits. Nitrosamines are chemical compounds sometimes found as impurities in medications due to manufacturing or storage conditions and are linked to an increased risk of cancer.
Details of the Recall
The voluntary recall, initiated by Teva Pharmaceuticals, covers 580,844 bottles distributed across the United States. These bottles vary in capsule counts from 100 up to 1,000 capsules per bottle. The FDA classified this recall as Class II, indicating that exposure to the affected medication could lead to temporary or medically reversible adverse health effects, with a low probability of serious consequences.
Affected lots have various expiration dates ranging from late 2025 through 2027. Patients are urged to check their medication lot numbers against the official FDA recall list and reach out to their healthcare provider if their medication is impacted.
Why Was the Recall Issued?
The recall was prompted by the detection of high levels of N-nitroso Prazosin impurity C during routine quality testing. This impurity falls under the category of nitrosamines, which are known carcinogens in laboratory animals and are reasonably anticipated to cause cancer in humans.
- While the immediate health risks of ingesting these levels are not fully quantified
- the FDA and Teva Pharmaceuticals acted proactively to minimize potential
- long-term cancer risks for patients taking this medication.
What Should Patients Do?
If you are currently taking Prazosin Hydrochloride capsules:
- Do not stop your medication suddenly. Abrupt discontinuation of blood pressure medication can cause serious health risks, including dangerous increases in blood pressure.
- Contact your healthcare provider or pharmacist immediately to discuss your prescription and possible alternatives or next steps.
- Check your medication’s lot number and expiration date against the FDA’s recall list to determine if your medication is part of the recall.
- Follow the guidance of your healthcare provider on safely transitioning to non-affected medication if necessary.
Additional Uses of Prazosin Hydrochloride
- Besides its primary use for hypertension, Prazosin Hydrochloride is sometimes
- prescribed to alleviate symptoms of PTSD, particularly nightmares and sleep disruptions.
- This makes the recall particularly significant for patients relying on the drug for
- mental health benefits as well as blood pressure control.
About Teva Pharmaceuticals
Teva Pharmaceuticals, based in Parsippany, New Jersey, is a leading generic drug manufacturer. The company has cooperated with the FDA in issuing this recall. So far, Teva has not reported receiving complaints related to adverse health effects from this medication impurity.
FDA Oversight and Public Safety
- The FDA’s classification of the recall as Class II underscores the agency’s commitment
- to protecting public health by managing risks associated with contaminated medications
- promptly. They continue to monitor the situation and provide updates
- to consumers and healthcare professionals.
The recall of over 580,000 bottles of Prazosin Hydrochloride blood pressure medication due to high levels of a cancer-causing impurity is a critical alert for patients and healthcare providers. Patients taking this medication should carefully check if they have the recalled lots and consult their doctors for safe alternatives. Sudden discontinuation is strongly discouraged due to health risks.
